The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus

Hormone and Metabolic Research

Volumn 31, Issue 10, 1999, Pages 564-569

  Hatziagelaki, E ^a,d   Jaeger, C ^a   Petzoldt, R ^b   Seissler, J ^c   Scherbaum, W A ^c   Federlin, K ^a   Bretzel, R G ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d NONE   (Greece)

Author keywords

Family Study; Islet Autoantibodies; Prediction of Type 1 Diabetes Mellitus

Indexed keywords

AUTOANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHILD; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0032742826     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978796     Document Type: Article

References (39)

1. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986; 314: 1360-1368
2. Boitard C, Debray-Sachs M, Pouplard A, Assan R, Hamburger J. Lymphocytes from diabetics suppress insulin release in vitro. Diabetologia 1981; 21: 41-46
3. Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudwotth AG. The natural history of Type I (insulin-dependent) diabetes mellitus: evidence for a long prediabetic period. Lancet 1981; II: 1363-1365
4. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; II: 1279-1283
5. Bonifacio E, Bingley PJ, Shattock M, Dunger D, Gale EAM, Bottazzo GF. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335: 147-149
6. Tarn AC, Thomas JM, Dean BM, et al. Predicting insulin-dependent diabetes. Lancet 1988; I: 845-850
7. Bonifacio E, Boitard C, Gleichmann H, Shattock MA, Molenaar JL, Bottazzo GF. Assessment of precision, concordance, specificity, and sensitivity of islet-cell antibody measurement in 41 assays. Diabetologia 1990; 33: 731-736
8. Lernmark A, Molenaar JL, van Beers WA, Yamaguchi Y, Nagataki S, Ludvigson J, Maclaren NK. The Fourth International Serum Exchange Workshop to standardise cytoplasmic islet cell antibodies: the Immunology and Diabetes Workshops and Participating Laboratories. Diabetologia 1991; 34: 534-535
9. Roll U, Christie MR, Standl E, Ziegler A. Association of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients. Diabetes 1994; 43: 154-160
10. Seissler J, Hering B, Richter W, et al. Anitbodies to the Mr 64000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function. Diabetologia 1992; 35: 550-554
11. Chaillous L, Delamaire M, Elmansour A, et al. Combined analysis of islet cell antibodies which cross-react with mouse pancreas, antibodies to the Mr 64000 islet cell protein, and antibodies to glutamate decarboxylase in subjects at risk for IDDM. Diabetologia 1994; 37: 491-499
12. Christie MR, Tun RYM, Lo SSS, et al. Antibodies to GAD and tryptic fragments of islet 64K antigen as distinct markers for development of IDDM. Diabetes 1992; 41: 782-786
13. Christie M, Genovese S, Cassidy D, et al. Antibodies to islet 37K antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity. Diabetes 1994; 43: 1254-1259
14. Bonifacio E, Genovese S, Braghi S, et al. Islet autoantibody markers in IDDM; risk assessment strategies yielding high sensitivity. Diabetologia 1995; 38: 816-822
15. Aanstoot HJ, Sigurdsson E, Jaffe M, et al. Value of antibodies to GAD-65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population. Diabetologia 1994; 37: 917-924
16. Yu L, Gianani R, Eisenbarth GS. Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type I diabetes. Diabetes 1994; 43: 1229-1233
17. Schott M, Schatz D, Atkinson M, et al. GAD-65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus. J Autoimmun 1994; 7: 865-872
18. Bingley PJ, Christie MR, Bonifacio E, et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43: 1304-1310
19. Payton MA, Hawkes CJ, Christie MR. Relationship of the 37000-and 40000 Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA 512). J Clin Invest 1995; 96: 1506-1511
20. Lan MS, Goto Y, Notkins AL. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994; 5: 505-514
21. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, Boel E, Michelsen B, Dyrberg T. Detection of GAD-65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994; 43: 459-467
22. Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA, and the DENIS Study Group. Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first-degree relatives of patients with IDDM. Diabetologia 1996; 39: 1351-1356
23. Maclaren NK. How, when and why to predict IDDM. Diabetes 1988; 37: 1591-1594
24. Atkinson MA, Maclaren NK, Scharp DW, Lacy PE, Riley WJ. 64000 Mr autoantibodies as predictors of insulin-dependent diabetes. Lancet 1990; 335: 1357-1360
25. Betterle C, Presotto F, Pedini B, Moro L, Slack RS, Zanette F, Zanchetta R. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type I (insulin-dependent) diabetes mellitus. A 10-year follow-up study. Diabetologia 1987; 30: 292-297
26. Riley WJ, Maclaren NK, Krischer J, et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990; 323: 1167-1172
27. Knip M, Vahasalo P, Karjalainen J, Lounamaa R, Akerblom HK, and the Childhood Diabetes in Finland Study group. Natural history of preclinical IDDM in high risk siblings. Diabetologia 1994; 37: 388-393
28. Christie M, Landin-Olsson M, Sundkvist G, Dahlquist G, Lernmark A, Baekkeskov S. Antibodies to a Mr 64000 islet cell protein in Swedish children with newly diagnosed Type I (insulin-dependent) diabetes. Diabetologia 1988; 31: 597-602
29. Baermeier H, McCulloch D, Neifing J, Rajotte R, Palmer J, Lernmark A. Progression of beta-cell dysfunction is associated with 64K antibodies in first degree relatives of IDDM patients. Diabetes 1990; 39 (Suppl 1): 122A
30. Seissler J, Amann J, Mauch L, et al. Prevalence of autoantibodies to the 65-and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1993; 92: 1394-1399
31. Verge CF, Howard NJ, Rowley MJ, et al. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 1994; 37: 1113-1120
32. Hagopian WA, Sanjeevi CB, Kockum I, et al. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995; 95: 1505-1511
33. Ongagna CJ, Marshal-Levy C. Anti-37 kDA antibodies are associated with the development of IDDM in individuals with islet cell antibodies. Diabetologia 1995; 38: 370-375
34. Thivolet CH, Tappaz M, Durand A, Petersen J, et al. Glutamic acid decarboxylase (GAD) autoantibodies are additonal predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia 1992; 35: 570-576
35. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM. Prediction of IDDM in the General Population - Strategies Based on Combinations of Autoantibody. Diabetes 1997; 46: 1701-1710
36. Simone E, Eisenbarth GS. Chronic Autoimmunity of Type 1 Diabetes. Horm Metab Res 1996; 28: 332-336
37. Bingley PJ, Bonifacio E, Shattock M, et al. Can islet cell antibodies predict IDDM in the general population? Diabetes care 1993; 16: 45-50
38. Roll U, Christie MR, Fuechtenbusch M, et al. Perinatal autoimmunity in offspring of diabetic parents: the German multicenter BABY-DIAB study. Detection of humoral immune responses to islet antigens in early childhood. Diabetes 1996; 45: 967-973
39. Kockum I, Lernmark A, Dahlquist G, et al. Genetic and immunological findings in patients with newly diagnosed insulin-dependent diabetes mellitus. Horm Metab Res 1996; 28: 344-347